Overview

Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer

Status:
Terminated
Trial end date:
2015-05-21
Target enrollment:
Participant gender:
Summary
This phase II trial studies how well Polyphenon E works in treating patients with high-risk of colorectal cancer. Polyphenon E contains ingredients that may prevent or slow colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Mayo Clinic
Collaborator:
National Cancer Institute (NCI)
Treatments:
Epigallocatechin gallate